Imvaq Therapeutics Revenue and Competitors

Claim your profile

Location

N/A

Total Funding

Biotech

Industry

Employee Data

  • Imvaq Therapeutics has 3 Employees.(i)
  • Imvaq Therapeutics grew their employee count by 0% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.4M6200%N/AN/A
#2
$2.1M3119%N/AN/A
#3
$32.9M1859%N/AN/A
#4
$0.5M50%$10MN/A
#5
$0.7M110%N/AN/A
#6
$7.5M32-3%$51.6MN/A
#7
$0.3M5-17%N/AN/A
#8
$4.3M21-9%$3.3MN/A
#9
$1.4M22-15%N/AN/A
#10
$0.5M717%N/AN/A
Add Company

Imvaq is an innovative biotechnology company developing novel immuno-oncologics to treat metastatic cancer. Based on the research of Imvaq's distinguished scientific founders at Memorial Sloan Kettering Cancer Center, one of the leading clinical and R&D cancer hospitals in the world, we are focused on creating therapeutic products that synergize with a patient's own immune system to eradicate the cancer, locally and abscopally.

keywords:N/A

N/A

Total Funding

3

Number of Employees

N/A

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0M30%$9M
#2
$0.5M30%N/A
#3
$0.2M3N/AN/A
#4
$0.2M3N/AN/A
#5
$0.2M3N/AN/A